Guidance For Industry Contract Manufacturing Arrangements For Drugs Quality Agreements
The guidelines refer to the relationship between “owners” and “contract organizations” and define owners as manufacturers of APIs, drugs, in-process materials, finished drugs (including biologics) and combined products. The term “owner” does not apply to retail pharmacies, pharmacies, supermarkets, discount stores or other retailers that purchase finished drugs and sell them as a non-prescription store brand. The guidelines define “contract organizations” as parties that perform one or more manufacturing transactions on behalf of an owner. The term “manufacturing” within the meaning of this document includes processing, packaging, thinking and labelling, quality testing and operations Unit.No subject matter whose activities are outsourced, the quality entity of the contracting entity (“owner”) remains ultimately responsible for the approval and refusal of drugs manufactured by the contract manufacturer (21 CFR 210.3 (12)). This is not the case in Europe, where authorisation (certification by a qualified person) can also be outsourced. In short, the fda expects “owners” to enter into quality written agreements with “contractual bodies” in which the parties define and define the roles and responsibilities of each party in ensuring the production of drugs and drugs in accordance with current good manufacturing practices. These quality agreements should ideally indicate which party performs which activities and which party is primarily responsible for full compliance with GMOs in accordance with Section 501 (a) (a) (2) (B) of the Act and 21 C.F.R. Parts 210, 211 and 600-680, since these rules may apply to the product or substance in question. The new guidelines highlight the need to identify who is responsible for installation and equipment activities that affect manufacturing processes. These include the definition of the person who supports the qualification of installation and equipment and the validation of processes. It should also cover systems that support the manufacturing process, including information technology and automated control systems, environmental monitoring and space classification, utilities and all other equipment and equipment that must be maintained to carry out contract-agreed manufacturing operations in accordance with the PMCs.